INTERFERON A/B/Y - ANVISA Registration 10322250079
Access comprehensive regulatory information for INTERFERON A/B/Y in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10322250079 and manufactured by QIAGEN. The registration is held by QIAGEN BIOTECNOLOGIA BRASIL LTDA. with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 1 companies making the same product including QIAGEN, and 1 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
10322250079
25351202367201747
01334250000120
Company Information
Dates and Status
Oct 31, 2017
VIGENTE
09/18/2025 19:00:01
ANTI-INTRINSIC FACTOR ANTIBODY
EliA Intrinsic Factor Well
PHADIA AB
80254180382
Feb 18, 2021
ANTI-INTRINSIC FACTOR ANTIBODY
ACCESS INTRINSIC FACTOR Ab QC
BECKMAN COULTER, INC.
10033120546
Jun 25, 2007
IMMUNOGLOBULIN E
Quantia Ferritin / Myoglobin / IgE Control
BIOKIT S. A.
80146501616
Oct 19, 2009
IMMUNOGLOBULIN A
ELIA IGA CONJUGATE 50
PHADIA AB
80254180058
Feb 21, 2007
ANTI-INFLIXIMAB (IFX) ANTIBODIES
Quantum Blue® Anti-Infliximab
Not specified
80102512585
Sep 24, 2020